US81362J3086 - Common Stock
SECOND SIGHT MEDICAL PRODUCT
NASDAQ:EYES (8/30/2022, 7:10:00 PM)
After market: 4.0921 -0.05 (-1.16%)4.14
-0.22 (-5.05%)
Second Sight Medical Products Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Sylmar, California and currently employs 15 full-time employees. The company went IPO on 2014-11-19. Second Sight Medical Products, Inc. is engaged in developing, manufacturing and marketing implantable visual prosthetics devices that restore vision to blind individuals. The firm manufactures neuromodulation devices for blindness and engaged in developing new technologies to treat sight-impaired individuals. Its approved product, the Argus II Retinal Prosthesis System (Argus II), treats outer retinal degenerations, such as retinitis pigmentosa (RP). The company is engaged in developing the Orion Visual Cortical Prosthesis System (Orion), an implanted cortical stimulation device, which provides artificial vision to individuals who are blind due to various causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease and eye injury. Orion works by converting video images captured by a miniature camera housed in a user’s glasses into a series of small electrical pulses that are transmitted wirelessly to an array of electrodes.
SECOND SIGHT MEDICAL PRODUCT
12744 San Fernando Road, Bldg. 3
Sylmar CALIFORNIA 91342
P: 18188335000.0
CEO: Matthew Pfeffer
Employees: 15
Website: http://www.secondsight.com/
We're starting the final day of trading this week with a look at the biggest pre-market stock movers for Friday and what's moving them!
Here you can normally see the latest stock twits on EYES, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: